Siemens Healthineers, DE000SHL1006

Siemens Healthineers stock results due November 5, 2026, slightly lower pre-market

Published on 10/22/2026 at 08:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The group provides medical technologies and services for clinical decision-making and treatment pathways. At Lang & Schwarz the stock trades pre-market at EUR 41.36 on October 22, 2026, 0.84 percent below the Xetra close of October 21, 2026.

Quarterly reporting date approaches

  • The Q4 results and analyst call are scheduled for November 5, 2026.
  • Siemens Healthineers provides products, services and solutions used in clinical decision-making and treatment pathways.
  • Siemens Healthineers stock trades pre-market at EUR 41.36 at 8:37 a.m. CEST at Lang & Schwarz on October 22, 2026, 0.84 percent below the Xetra close of October 21, 2026.
Siemens Healthineers DE000SHL1006 gestaltet Bauhaus-Poster mit geometrischen Formen und stilisiertem Scanner-Ring sowie MEDTECH-Schriftzug, Illustration mit AI erstellt.

Siemens Healthineers' investor-relations calendar lists November 5, 2026, for its fourth-quarter results and analyst call, according to the company's investor-relations page. Siemens Healthineers stock trades pre-market at EUR 41.36 at 8:37 a.m. CEST at Lang & Schwarz on October 22, 2026, 0.84 percent below the Xetra close of October 21, 2026 (EUR 41.71).

Results date on the calendar

The company has scheduled its fourth-quarter results and analyst call for November 5, 2026, with the event listed as online in the investor-relations calendar. The calendar also identifies November 6, 2026, as a U.S. roadshow date.

Ahead of the Xetra open

The pre-market indication is EUR 0.35 below the reference close. The bid is EUR 41.07 and the ask is EUR 41.64, a spread of 1.38 percent. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Siemens Healthineers stock.

The group and its market

Siemens Healthineers provides products, services and solutions used in clinical decision-making and treatment pathways, according to its investor-relations page. The next own calendar item is the fourth-quarter results and analyst call on November 5, 2026. Market context: Market report DAX.

More news and analysis on Siemens Healthineers stock

Disclaimer...
en | DE000SHL1006 | SIEMENS HEALTHINEERS | boerse | 70390983 | bgmi